BRNS

#4613
Barinthus Biotherapeutics plc American Depositary Shares
0.60 USD
+9.09%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
0.60
0.60
Rango anual
0.51
2.92
Cambio diario
+9.09%
Variación mensual
-6.25%
Variación en los últimos 6 meses
-54.89%
Cambio anual
-14.29%
Cierres anteriores
0.55
Abrir
0.60
Bid
Ask
Mínimo
0.60
High
0.60
Volumen
1
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 24.51 M
  • Employee 14
  • Founded 2016
  • CEO N/A
  • Website www.barinthusbio.com
  • Headquarter United Kingdom
  • FIGI BBG00ZZPCP09
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.43
Relación precio/flujo de caja
—

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people.

Noticias